Clinical Trials Browser

Breast Neoplasms, Breast Neoplasms, Male

NCT00066690 2026-02-06

SOFT

Phase 3 Completed

3,066 enrolled 15 charts

Breast

Breast Neoplasms

NCT05512364 2025-08-19

TREAT ctDNA

Phase 3 Recruiting

220 enrolled

Breast

Breast Neoplasms

NCT00295646 2024-03-15

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

Phase 3 Completed

1,803 enrolled 20 charts

Breast

Breast Neoplasms

NCT00309478 2023-06-29

Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients

Phase 3 Completed

1,099 enrolled

Breast

Breast Neoplasms

NCT00004125 2023-06-15

Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes

Phase 3 Completed

Breast

Breast Neoplasms

NCT00003857 2022-05-25

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

Phase 3 Completed

636 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00309491 2020-10-19

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

Phase 3 Completed

2,021 enrolled

Breast

Breast Neoplasms

NCT00002864 2020-04-01

Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer

Phase 3 Completed

667 enrolled

Breast

Breast Neoplasms

NCT00003032 2020-04-01

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer

Phase 3 Completed

224 enrolled

Breast

Breast Neoplasms

NCT00659373 2016-07-25

Co-SOFT

Phase 3 Completed

86 enrolled 4 charts

Breast

Breast Neoplasms, Fatigue, Sleep Wake Disorders

NCT00003906 2015-10-06

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women

Phase 3 Completed

19,747 enrolled

Breast

Breast Neoplasms

NCT00016341 2013-04-11

Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer

Phase 3 Terminated

Gynecologic

Endometrial Neoplasms

NCT00002528 2013-04-04

10-93

Phase 3 Completed

473 enrolled

Breast

Breast Neoplasms

NCT00002529 2013-04-04

12-93

Phase 3 Completed

452 enrolled

Breast

Breast Neoplasms

NCT00002784 2013-04-04

15-95

Phase 3 Completed

344 enrolled

Breast

Breast Neoplasms

NCT00002772 2013-01-24

S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Phase 3 Terminated

602 enrolled

Breast

Breast Neoplasms

NCT00929591 2013-01-24

SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer

Phase 3 Completed

1,558 enrolled

Breast

Breast Neoplasms

NCT00002920 2012-10-31

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

Phase 3 Completed

313 enrolled

BreastGynecologic

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Paget's Disease, Mammary, Endometrial Neoplasms

NCT00002777 2012-07-02

Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Phase 3 Completed

342 enrolled

Breast

Breast Neoplasms

NCT00002707 2010-02-03

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

Phase 3 Completed

2,411 enrolled

Breast

Breast Neoplasms

Clinical Trials

e3

SOFT

TREAT ctDNA

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients

Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer

Co-SOFT

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women

Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer

10-93

12-93

15-95

S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed